AstraZeneca
AZN
AZN
530 hedge funds and large institutions have $14B invested in AstraZeneca in 2018 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 144 increasing their positions, 197 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
530
Holders Change
+13
Holders Change %
+2.51%
% of All Funds
12.15%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
61
Increased
144
Reduced
197
Closed
43
Calls
$164M
Puts
$57.1M
Net Calls
+$107M
Net Calls Change
+$53.4M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$677M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$185M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$76.5M |
| 4 |
Primecap Management
Pasadena,
California
|
+$51.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$51M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$337M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$67.4M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$61.6M |
| 4 |
Goldman Sachs
New York
|
-$56.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$52.5M |